# Cardiolite

NDC: 11994-001
Generic name: TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
Labeler / Manufacturer: Lantheus Medical Imaging, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 19901220

FDA application: NDA019785

## Active ingredients

- TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE: 1 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"11994-001"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=11994-001
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=49662def-2fb9-47b2-8467-ca56f6006167